Preoperative TNFi Not Associated With Postoperative Infections in IBD
Researchers sought to determine if receiving treatment with TNF inhibitors prior to surgery would increase the risk for postoperative infection.
Gastrointestinal Illnesses
Can Fecal Microbiota Transplantation Become a Standard of Care for Ulcerative Colitis?
Studies show fecal microbiota transplantation (FMT) can help patients with ulcerative colitis (UC) achieve remission, but challenges must be addressed before FMT can become a standard of treatment for UC.
H heilmannii Infection Linked to Chronic Gastritis Among Patients With Dyspepsia
A team of researchers sought to determine how often H heilmannii developed among patients with upper gastrointestinal symptoms.
GI Symptoms Do Not Affect Enteral Nutrition Delivery in Patients With COVID-19
Researchers analyzed the relationship between GI symptoms and nutritional intake through enteral nutrition in patients critically ill with COVID-19.
PPIs Linked to Higher Risk for Infection, Decompensation in Cirrhosis
Researchers investigated the relationship between proton pump inhibitor exposure and infection, decompensation, and all-cause mortality in liver cirrhosis.
Ampicillin Resistance Common in Escherichia coli Isolates From Children With Diarrhea
Investigators assessed antimicrobial resistant profiles of Escherichia coli pathotypes detected via fecal swabs among children with diarrhea from Mozambique.
COPD and Future Functional Gastrointestinal Disorders
Is there an association between COPD and functional gastrointestinal disorders, including GERD, irritable bowel syndrome, and functional dyspepsia?
Prognostic Model Predicts Survival in Elderly With GI Diffuse Large B-Cell Lymphoma
A prognostic model based on clinical parameters has been developed and validated for predicting overall survival among elderly patients with EGI DLBCL.
Concomitant PPI and Advanced Therapy Linked to Worse Outcomes in IBD
A team of investigators evaluated the effects of concomitant use of PPIs and advanced therapy on health care resources in patients with IBD.
Oral Microbiome Therapy Sustains Clinical Cure for Recurrent C difficile
Presenting at DDW 2022, researchers evaluated data from the PRISM3 placebo-controlled trial and the PRISM-EXT open-label extension trial of CP101, an investigational microbiome therapeutic.
- Loading...
Loading...
Next post in GI Illness
Loading... 
Loading...